• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤免疫微环境中的损伤相关分子模式和 Toll 样受体。

Damage-associated molecular patterns and Toll-like receptors in the tumor immune microenvironment.

机构信息

Department of Inflammology, Research Center for Advanced Science and Technology, University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan.

出版信息

Int Immunol. 2021 Nov 25;33(12):841-846. doi: 10.1093/intimm/dxab050.

DOI:10.1093/intimm/dxab050
PMID:34357403
Abstract

As clinically demonstrated by the success of immunotherapies to improve survival outcomes, tumors are known to gain a survival advantage by circumventing immune surveillance. A defining feature of this is the creation and maintenance of a tumor immune microenvironment (TIME) that directly and indirectly alters the host's immunologic signaling pathways through a variety of mechanisms. Tumor-intrinsic mechanisms that instruct the formation and maintenance of the TIME have been an area of intensive study, such as the identification and characterization of soluble factors actively and passively released by tumor cells that modulate immune cell function. In particular, damage-associated molecular pattern (DAMP) molecules typically released by necrotic tumor cells are recognized by innate immune receptors such as Toll-like receptors (TLRs) and stimulate immune cells within TIME. Given their broad and potent effects on the immune system, a better understanding for how DAMP and TLR interactions sculpt the TIME to favor tumor growth would identify new strategies and approaches for cancer immunotherapy.

摘要

正如免疫疗法在提高生存率方面的成功所临床证明的那样,肿瘤通过规避免疫监视获得生存优势。其一个明确的特征是创建和维持肿瘤免疫微环境(TIME),通过多种机制直接和间接改变宿主的免疫信号通路。指导 TIME 形成和维持的肿瘤内在机制一直是深入研究的领域,例如鉴定和表征肿瘤细胞主动和被动释放的可调节免疫细胞功能的可溶性因子。特别是,损伤相关分子模式(DAMP)分子通常由坏死肿瘤细胞释放,被先天免疫受体(如 Toll 样受体(TLR))识别,并刺激 TIME 内的免疫细胞。鉴于它们对免疫系统的广泛而强大的影响,更好地了解 DAMP 和 TLR 相互作用如何塑造 TIME 以促进肿瘤生长,将为癌症免疫疗法确定新的策略和方法。

相似文献

1
Damage-associated molecular patterns and Toll-like receptors in the tumor immune microenvironment.肿瘤免疫微环境中的损伤相关分子模式和 Toll 样受体。
Int Immunol. 2021 Nov 25;33(12):841-846. doi: 10.1093/intimm/dxab050.
2
Toll-Like Receptors Signaling in the Tumor Microenvironment.肿瘤微环境中的 Toll 样受体信号转导。
Adv Exp Med Biol. 2020;1223:81-97. doi: 10.1007/978-3-030-35582-1_5.
3
DAMP-TLR-cytokine axis dictates the fate of tumor.DAMP-TLR-cytokine 轴决定肿瘤的命运。
Cytokine. 2018 Apr;104:114-123. doi: 10.1016/j.cyto.2017.10.004. Epub 2017 Oct 9.
4
Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy.了解 Toll 样受体在肺癌免疫和免疫治疗中的作用。
Front Immunol. 2022 Oct 31;13:1033483. doi: 10.3389/fimmu.2022.1033483. eCollection 2022.
5
Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.肿瘤微环境中的 Toll 样受体 (TLRs):非虚构游戏《权力的游戏》中的屠龙之刃。
Adv Exp Med Biol. 2020;1263:145-173. doi: 10.1007/978-3-030-44518-8_9.
6
Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.天然免疫中的 Toll 样受体 (TLRs)、NOD 样受体 (NLRs) 和 RIG-I 样受体 (RLRs)。TLRs、NLRs 和 RLRs 配体作为造血疾病的免疫治疗药物。
Int J Mol Sci. 2021 Dec 13;22(24):13397. doi: 10.3390/ijms222413397.
7
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.TLR 介导的肿瘤微环境代谢重编程:癌症免疫治疗的潜在新策略。
Cell Mol Immunol. 2018 May;15(5):428-437. doi: 10.1038/cmi.2018.4. Epub 2018 Mar 19.
8
Interactions between tumor-derived proteins and Toll-like receptors.肿瘤源性蛋白与 Toll 样受体的相互作用。
Exp Mol Med. 2020 Dec;52(12):1926-1935. doi: 10.1038/s12276-020-00540-4. Epub 2020 Dec 9.
9
Toll-like receptors, tissue injury, and tumourigenesis. toll 样受体、组织损伤与肿瘤发生
Mediators Inflamm. 2010;2010. doi: 10.1155/2010/581837. Epub 2010 Sep 14.
10
Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth.超越生死的对话:肿瘤微环境中的坏死及其对肿瘤生长的贡献。
Int J Mol Sci. 2023 Mar 9;24(6):5278. doi: 10.3390/ijms24065278.

引用本文的文献

1
Development of a prognostic prediction model based on damage-associated molecular pattern for colorectal cancer applying bulk RNA-seq analysis.基于损伤相关分子模式,应用批量RNA测序分析开发结直肠癌预后预测模型。
Sci Rep. 2025 Jul 16;15(1):25792. doi: 10.1038/s41598-025-10592-z.
2
regulates MSU-induced apoptosis and inflammatory response through TLR4/MyD88/NF-κB signaling pathway.通过TLR4/MyD88/NF-κB信号通路调节单钠尿酸盐诱导的细胞凋亡和炎症反应。
Int J Med Sci. 2025 Jun 23;22(12):3070-3083. doi: 10.7150/ijms.112102. eCollection 2025.
3
Regulation of Different Types of Cell Death by Noncoding RNAs: Molecular Insights and Therapeutic Implications.
非编码RNA对不同类型细胞死亡的调控:分子机制与治疗意义
ACS Pharmacol Transl Sci. 2025 Apr 30;8(5):1205-1226. doi: 10.1021/acsptsci.4c00681. eCollection 2025 May 9.
4
Machine learning‑based construction of damage‑associated molecular patterns related score identifies subtypes of pancreatic adenocarcinoma with distinct prognosis.基于机器学习构建的损伤相关分子模式相关评分可识别出具有不同预后的胰腺腺癌亚型。
Oncol Lett. 2025 Mar 24;29(5):246. doi: 10.3892/ol.2025.14992. eCollection 2025 May.
5
Role of Adenosine A1 Receptor in Sleep Deprivation-Induced Neuroinflammation: Insights on Rapid Eye Movement Sleep and Fear Extinction Memory Recall in Rats.腺苷A1受体在睡眠剥夺诱导的神经炎症中的作用:对大鼠快速眼动睡眠和恐惧消退记忆回忆的见解
Cureus. 2024 Dec 18;16(12):e75926. doi: 10.7759/cureus.75926. eCollection 2024 Dec.
6
Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cells.免疫细胞和癌细胞中 Toll 样受体激动剂、L-pampo 信号通路的基于网络的比较分析。
Sci Rep. 2024 Jul 26;14(1):17173. doi: 10.1038/s41598-024-67000-1.
7
Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).靶向肿瘤相关巨噬细胞:肿瘤进展和治疗策略中的关键角色(综述)。
Int J Oncol. 2024 Jun;64(6). doi: 10.3892/ijo.2024.5648. Epub 2024 May 2.
8
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Toll 样受体导向的人类癌症治疗干预:分子和免疫学观点。
Front Immunol. 2023 Sep 26;14:1244345. doi: 10.3389/fimmu.2023.1244345. eCollection 2023.
9
adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll-like receptor 4.FimH 黏附部分通过 Toll 样受体 4 将肿瘤微环境中的 M2 巨噬细胞极化为 M1 巨噬细胞。
Front Immunol. 2023 Sep 1;14:1213467. doi: 10.3389/fimmu.2023.1213467. eCollection 2023.
10
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review.小儿脑肿瘤微环境的免疫生物学与细胞因子调节:一项范围综述
Cancers (Basel). 2023 Jul 18;15(14):3655. doi: 10.3390/cancers15143655.